Gregory Cote to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Gregory Cote has written about Xenograft Model Antitumor Assays.
Connection Strength
0.055
-
TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis. Oncotarget. 2015 Apr 10; 6(10):7504-21.
Score: 0.028
-
NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. Gynecol Oncol. 2015 Apr; 137(1):134-42.
Score: 0.027